Vetaş was established in 1973 to manufacture and market animal health and agricultural products, and is currently an industry leader animal health products. With 43 years of experience in preventing and treating disease, Vetaş has one of the largest product ranges in the industry.
Vetaş products are toll manufactured at DEVA Holding manufacturing plants which have GMP (Good Manufacturing Practice) certification from the Ministry of Food, Agriculture and Animal Husbandry. Vetaş relies on support from DEVA Holding Devarge division, one of the largest R&D centers in Turkey, for product research and development.
Vetaş is successfully integrated with the SAP and SOP systems implemented within DEVA. SAP, the world’s best and most effective reporting system, makes it possible to track and trace products in every step from purchasing of raw materials to delivery to the final consumer.
Filings are underway around the world for animal health products manufactured for Vetaş at DEVA Holding manufacturing facilities.
Vetaş undertakes investments within Turkey and initiatives around the world to support its mission of offering modern solutions to veterinarians for protecting animal health and treating diseases
Vetaş Veteriner ve Tarım İlaçları A.Ş. is established to manufacture and market veterinary and agricultural products.
The first products placed on the market were Vetimisin Powder for Solution for Injection and Vitaform Powder for Oral Solution. Vetimisin remains the market leader since the first day it was placed on the market.
Vetaş Oksitosin , the first oxytocin for veterinary use, and Vetaş Atropin, the first anticholinergic product in the Turkish market, are launched
DEVA Holding, Vetaş’s parent company, begins manufacturing Gentamycin at its active substance manufacturing facilities, becoming one of the first 5 companies in the world that can manufacture this agent. Initiated R&D for Gentamycin-containing products for veterinary use.
The first Gentamycin-containing products are launched in the market: Gentavet Solution for Injection, Gentavet-G Eye and Ear Drops, and Gentavet-D Skin ointment.
Gentavet 10% Solution for Injection is launched.
East Pharma S.A.R.L. acquires majority stake in DEVA Holding, Vetaş’s parent company.
Vetaş moves to DEVA Holding head office building in Halkalı.
SAP (Systems, Applications and Products in Data Processing), the world’s best and most effective reporting system for manufacturing sales and supply channels, is successfully introduced.
Helminoks Oral Tablets, an antiparasitic product containing oxfendazole and oxyclozanide, is launched.
Enteroks Powder for Oral Solution, an antibacterial product containing oxytetracycline and sulphadimidine, is launched.
Levazanid Oral Tablets, an antihelmintik product containing levamisole and oxyclozanide, is launched
Vetaş celebrates 40th year in the industry.
Vetaş enhances product range with 11 products.
DEVA Holding facilities, toll manufacturing products for Vetaş, receives GMP certification by Turkish Ministry of Food, Agriculture and Animal Husbandry.
Vetaş introduces the pre-dispensed Beta-lactam group of products.
Vetaş introduces the first BFS-packed parenteral products in the sector (Vetkalfos Solution for Injection, Fulltonic Solution for Injection, Hydrafull Solution for Injection).
18 products were introduced, adding value to the product range.
Aquaculture products (Diaqua, Geosol fish, Seaflor) were introduced as a new product segment.
Launched Vetakademi Kampüs, with the slogan “Led by Science,” with educational meetings to respond to scientific needs of veterinarians.
Vetamoks LA Suspension for Injection, an antibacterial containing amoxicillin, Vetkalfos Solution for Injection, a BSF product, and Setrim Powder for Oral Solution, containing erythromycin.
As of 30.12.2016, it has merged with DEVA Holding A.Ş., the main shareholder in the company. It will continue operating within DEVA Holding A.Ş. with the Vetaş brand.
Our mission is to offer veterinarians and animal breeders with customer-oriented, modern, high-quality and cost-effective solutions, recognizing the importance of animal health for human health.
Our vision is to become a dynamic, innovative, and solution-oriented pharmaceutical company that supports rational drug use, and monitors and rapidly adapts to changing conditions, while growing steadily in the animal health products market.
• Innovation and development
• Human focus
Vetaş products are toll manufactured at DEVA Holding manufacturing facilities. To learn more about the manufacturing facilities, visit